ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2021 | $1,840,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 19, 2021 | $1,840,000 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage and value; Developing an Innovative Strategy for Antimicrobial Resistant Microorganism Act of 2019 (DISARM Act); American Rescue Plan Act, 2021 (HR.1319)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL New | — |
| THOMAS CORDREY ROBERGE New | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Taxation/Internal Revenue Code TAX
Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; Pension and retirement benefit issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE | — |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Copyright/Patent/Trademark CPT
Pharmaceutical intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE New | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Consumer Issues/Safety/Products CSP
Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL New | — |
| THOMAS CORDREY ROBERGE | — |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Trade (domestic/foreign) TRD
Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-Kenta, and US-Brazil
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BURKHEAD | — |
| HEATHER CLARK New | — |
| SARAH KYLE | — |
| SHAWN O'NEAIL New | — |
| THOMAS CORDREY ROBERGE | — |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Health Issues HCR
Patient protection; Drug supply chain and shortages; Drug pricing, value and access; Transparency; Intellectual property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act"; American Rescue Plan Act, 2021 (HR.1319)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL New | — |
| THOMAS CORDREY ROBERGE New | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Immigration IMM
Administration Immigration Proclamation on non-immigrant visa categories
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
Pharmacy PHA
Hospital discounts; 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE New | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER New | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.